These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 23582061)

  • 61. Amlexanox attenuates experimental autoimmune encephalomyelitis by inhibiting dendritic cell maturation and reprogramming effector and regulatory T cell responses.
    Quan MY; Song XJ; Liu HJ; Deng XH; Hou HQ; Chen LP; Ma TZ; Han X; He XX; Jia Z; Guo L
    J Neuroinflammation; 2019 Mar; 16(1):52. PubMed ID: 30823934
    [TBL] [Abstract][Full Text] [Related]  

  • 62. IFN-β regulates Th17 differentiation partly through the inhibition of osteopontin in experimental autoimmune encephalomyelitis.
    Zhao Q; Cheng W; Xi Y; Cao Z; Xu Y; Wu T; Li C; Niu X; Chen G
    Mol Immunol; 2018 Jan; 93():20-30. PubMed ID: 29127843
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Inhibition of Interferon Regulatory Factor 4 Suppresses Th1 and Th17 Cell Differentiation and Ameliorates Experimental Autoimmune Encephalomyelitis.
    Yang C; He D; Yin C; Tan J
    Scand J Immunol; 2015 Oct; 82(4):345-51. PubMed ID: 26110284
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Melatonin enhances interleukin-10 expression and suppresses chemotaxis to inhibit inflammation in situ and reduce the severity of experimental autoimmune encephalomyelitis.
    Chen SJ; Huang SH; Chen JW; Wang KC; Yang YR; Liu PF; Lin GJ; Sytwu HK
    Int Immunopharmacol; 2016 Feb; 31():169-77. PubMed ID: 26735612
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Arctigenin Suppress Th17 Cells and Ameliorates Experimental Autoimmune Encephalomyelitis Through AMPK and PPAR-γ/ROR-γt Signaling.
    Li W; Zhang Z; Zhang K; Xue Z; Li Y; Zhang Z; Zhang L; Gu C; Zhang Q; Hao J; Da Y; Yao Z; Kong Y; Zhang R
    Mol Neurobiol; 2016 Oct; 53(8):5356-66. PubMed ID: 26440666
    [TBL] [Abstract][Full Text] [Related]  

  • 66. CCDC134 ameliorated experimental autoimmune encephalomyelitis by suppressing Th1 and Th17 cells.
    Xia P; Gong X; Xiao L; Wang Y; Zhang T; Liao Q; Mo X; Qiu X; Huang J
    Brain Behav Immun; 2018 Jul; 71():158-168. PubMed ID: 29548993
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Th17 cell, the new player of neuroinflammatory process in multiple sclerosis.
    Jadidi-Niaragh F; Mirshafiey A
    Scand J Immunol; 2011 Jul; 74(1):1-13. PubMed ID: 21338381
    [TBL] [Abstract][Full Text] [Related]  

  • 68. An Oriental Medicine, Hyungbangpaedok-San Attenuates Motor Paralysis in an Experimental Model of Multiple Sclerosis by Regulating the T Cell Response.
    Choi JH; Lee MJ; Jang M; Kim EJ; Shim I; Kim HJ; Lee S; Lee SW; Kim YO; Cho IH
    PLoS One; 2015; 10(10):e0138592. PubMed ID: 26444423
    [TBL] [Abstract][Full Text] [Related]  

  • 69. T cell subsets and their signature cytokines in autoimmune and inflammatory diseases.
    Raphael I; Nalawade S; Eagar TN; Forsthuber TG
    Cytokine; 2015 Jul; 74(1):5-17. PubMed ID: 25458968
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Transcription Factor RUNX3 Mediates Plasticity of ThGM Cells Toward Th1 Phenotype.
    Rasouli J; Casella G; Zhang W; Xiao D; Kumar G; Fortina P; Zhang GX; Ciric B; Rostami A
    Front Immunol; 2022; 13():912583. PubMed ID: 35860266
    [TBL] [Abstract][Full Text] [Related]  

  • 71. FOXP3 and RORγt: transcriptional regulation of Treg and Th17.
    Chen Z; Lin F; Gao Y; Li Z; Zhang J; Xing Y; Deng Z; Yao Z; Tsun A; Li B
    Int Immunopharmacol; 2011 May; 11(5):536-42. PubMed ID: 21081189
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Salmon proteoglycan suppresses progression of mouse experimental autoimmune encephalomyelitis via regulation of Th17 and Foxp3(+) regulatory T cells.
    Sashinami H; Asano K; Yoshimura S; Mori F; Wakabayashi K; Nakane A
    Life Sci; 2012 Dec; 91(25-26):1263-9. PubMed ID: 23069584
    [TBL] [Abstract][Full Text] [Related]  

  • 73. MBD2 regulates TH17 differentiation and experimental autoimmune encephalomyelitis by controlling the homeostasis of T-bet/Hlx axis.
    Zhong J; Yu Q; Yang P; Rao X; He L; Fang J; Tu Y; Zhang Z; Lai Q; Zhang S; Kuczma M; Kraj P; Xu JF; Gong F; Zhou J; Wen L; Eizirik DL; Du J; Wang W; Wang CY
    J Autoimmun; 2014 Sep; 53():95-104. PubMed ID: 24934598
    [TBL] [Abstract][Full Text] [Related]  

  • 74. In Vivo Induction of Regulatory T Cells Via CTLA-4 Signaling Peptide to Control Autoimmune Encephalomyelitis and Prevent Disease Relapse.
    Kim GR; Kim WJ; Lim S; Lee HG; Koo JH; Nam KH; Kim SM; Park SD; Choi JM
    Adv Sci (Weinh); 2021 Jul; 8(14):2004973. PubMed ID: 34306974
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Carnosol Modulates Th17 Cell Differentiation and Microglial Switch in Experimental Autoimmune Encephalomyelitis.
    Li X; Zhao L; Han JJ; Zhang F; Liu S; Zhu L; Wang ZZ; Zhang GX; Zhang Y
    Front Immunol; 2018; 9():1807. PubMed ID: 30150982
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Remote control of T
    Vijitha N; Engel DR
    J Leukoc Biol; 2019 May; 105(5):827-828. PubMed ID: 30958568
    [TBL] [Abstract][Full Text] [Related]  

  • 77. BJ-2266 ameliorates experimental autoimmune encephalomyelitis through down-regulation of the JAK/STAT signaling pathway.
    You Z; Timilshina M; Jeong BS; Chang JH
    Eur J Immunol; 2017 Sep; 47(9):1488-1500. PubMed ID: 28681958
    [TBL] [Abstract][Full Text] [Related]  

  • 78. The Spatio-Temporal Expression Profiles of CD4 + T Cell Differentiation and Function-Related Genes During EAE Pathogenesis.
    Cai Y; Shen H; Qin C; Zhou J; Lai W; Pan J; Du C
    Inflammation; 2017 Feb; 40(1):195-204. PubMed ID: 27882475
    [TBL] [Abstract][Full Text] [Related]  

  • 79. CDK inhibitors suppress Th17 and promote iTreg differentiation, and ameliorate experimental autoimmune encephalomyelitis in mice.
    Yoshida H; Kotani H; Kondo T; Tani I; Wei X; Tsuruta S; Kimura A; Asakawa M; Ito M; Nagai S; Yoshimura A
    Biochem Biophys Res Commun; 2013 Jun; 435(3):378-84. PubMed ID: 23665028
    [TBL] [Abstract][Full Text] [Related]  

  • 80. The CREB/CRTC2 pathway modulates autoimmune disease by promoting Th17 differentiation.
    Hernandez JB; Chang C; LeBlanc M; Grimm D; Le Lay J; Kaestner KH; Zheng Y; Montminy M
    Nat Commun; 2015 Jun; 6():7216. PubMed ID: 26031354
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.